Liquiritigenin, a flavonoid aglycone from licorice, has a choleretic effect and the ability to induce hepatic transporters and phase-II enzymes
Kim YW (Kim, Young Woo), Kang HE (Kang, Hee Eun), Lee MG (Lee, Myung Gull), Hwang SJ (Hwang, Se Jin), Kim SC (Kim, Sang Chan), Lee CH (Lee, Chang Ho), Kim SG (Kim, Sang Geon)
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2009
112
Role of hepatitis B virus X repression of C/EBP activity in the down-regulation of glutathione S-transferase A2 gene: implications in other phase II detoxifying enzyme expression
조일제, 기성환, Brooks C (Brooks, C., III), 김상건
XENOBIOTICA, 2009
113
Inhibition of Arachidonic Acid and Iron-Induced Mitochondrial Dysfunction and Apoptosis by Oltipraz and Novel 1,2-Dithiole-3-thione Congeners
Shin, SM, Kim, SG
MOLECULAR PHARMACOLOGY, 2009
114
A Novel Mitogen-Activated Protein Kinase Phosphatase-1 and Glucocorticoid Receptor (GR) Interacting Protein-1-Dependent Combinatorial Mechanism of Gene Transrepression by GR
Cho IJ (Cho, Il Je), Kim SG (Kim, Sang Geon)
MOLECULAR ENDOCRINOLOGY, 2009
115
Compound C inhibits clonal expansion of preadipocytes by increasing p21 level irrespectively of AMPK inhibition
김상건, 남민우, 배은주, 이우형
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2008
116
The identification of C/EBP beta as a transcription factor necessary for the induction of MAPK phosphatase-1 by toll-like receptor-4 ligand
김상건, 조일제, 우나리
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2008
117
DRUG-INDUCED HYPERBILIRUBINEMIA AND THE CLINICAL INFLUENCING FACTORS
김상건, 아영미, 김영미, 최영희, 박경호, 손인자, 김민정
DRUG METABOLISM REVIEWS, 2008
118
Regulation of thymus-dependent and thymus-independent production of immunoglobulin G subclasses by Galpha12 and Galpha13
이송진, 이우형, 이창호, 김상건
JOURNAL OF MOLECULAR SIGNALING, 2008
119
Isoliquiritigenin suppresses cocaine-induced extracellular dopamine release in rat brain through GABA(B) receptor
김상건, 양채하, 장은영, Eun Sang Choe, Meeyul Hwang, 김상찬, 이종록, Jae-Pil Jeon, Russell J. Buono
EUROPEAN JOURNAL OF PHARMACOLOGY, 2008
120
Effects of E-coli Lipopolysaccharide on the Pharmacokinetics of Ipriflavone and Its Metabolites, M1 and M5, after Intravenous and Oral Administration of Ipriflavone to Rats: Decreased Metabolism of Ipriflavone Due to Decreased Expression of Hepatic CYP1A2 and 2C11